Search by Drug Name or NDC
NDC 49873-0403-01 Inon Ace 250; 900 mg/30mL; mg/30mL Details
Inon Ace 250; 900 mg/30mL; mg/30mL
Inon Ace is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Sato Pharmaceutical Co., Ltd.. The primary component is MAGNESIUM HYDROXIDE; SILODRATE.
Product Information
| NDC | 49873-0403 |
|---|---|
| Product ID | 49873-403_0bde7bd2-8a69-57b4-e063-6394a90a00d2 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Inon Ace |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | magnesium aluminosilicate, magnesium hydroxide |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 250; 900 |
| Active Ingredient Units | mg/30mL; mg/30mL |
| Substance Name | MAGNESIUM HYDROXIDE; SILODRATE |
| Labeler Name | Sato Pharmaceutical Co., Ltd. |
| Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M001 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 49873-0403-01 (49873040301)
| NDC Package Code | 49873-403-01 |
|---|---|
| Billing NDC | 49873040301 |
| Package | 2 BOTTLE in 1 CARTON (49873-403-01) / 30 mL in 1 BOTTLE |
| Marketing Start Date | 2000-05-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |